{"id":"W3095175361","doi":"10.1182/blood-2020-142275","title":"Phase I/II Dose-Escalation Study of Lenalidomide in Combination with R-GDP for Treatment of Transplant-Ineligible Relapsed/Refractory Diffuse Large B-Cell Lymphoma Followed By Maintenance Lenalidomide","year":2020,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Northeast Cancer Centre","funders":"","keywords":"Lenalidomide; Medicine; Neutropenia; Gemcitabine; Internal medicine; Regimen; Febrile neutropenia; Phases of clinical research; Diffuse large B-cell lymphoma; Rituximab; Refractory (planetary science); Progressive disease; Salvage therapy; Oncology; Gastroenterology; Surgery; Dexamethasone; Lymphoma; Clinical trial; Chemotherapy; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002487599,0.001697463,0.002237654,0.0007941062,0.0005151456,0.001250177,0.001611908,0.001402517,0.002396893],"category_scores_gemma":[0.00102033,0.001003487,0.001197329,0.0005765477,0.001483874,0.0008854809,0.0004816605,0.004948754,0.0006611982],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001317273,"about_ca_system_score_gemma":0.002111475,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0008465096,"about_ca_topic_score_gemma":0.002395964,"domain_scores_codex":[0.9989136,0.0005539935,0.00005883919,0.0001799382,0.00009335116,0.0002002085],"domain_scores_gemma":[0.999,0.0001326406,0.0002062619,0.0001322119,0.0000678657,0.0004610245],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.5273147,0.2719021,0.005065403,0.0005027766,0.0009526955,0.000273708,0.0004834093,0.004433427,0.1259201,0.0004290946,0.002606827,0.06011581],"study_design_scores_gemma":[0.3962651,0.5846204,0.005037524,0.00002167845,0.0002269772,0.0001875495,0.00004266459,0.001281731,0.01048423,0.0001655548,0.001634547,0.0000321327],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9936165,0.000537478,0.0006172779,0.000284269,0.00007366928,0.003290912,0.0005747967,0.00008401037,0.0009211986],"genre_scores_gemma":[0.98943,0.0005861414,0.003106846,0.0005475213,0.0001099975,0.00328311,0.001344122,0.00003481781,0.001557454],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002487599,"threshold_uncertainty_score":0.01315582,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01719857402912654,"score_gpt":0.2624839824502298,"score_spread":0.2452854084211033,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}